These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32826483)

  • 21. A pragmatic analysis comparing once-monthly paliperidone palmitate versus daily oral antipsychotic treatment in patients with schizophrenia.
    Alphs L; Mao L; Lynn Starr H; Benson C
    Schizophr Res; 2016 Feb; 170(2-3):259-64. PubMed ID: 26742509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Paliperidone Palmitate Treatment in Patients With Schizophrenia: A Real-World Multicenter, Retrospective, Mirror-Image Study.
    Devrimci-Ozguven H; Atmaca M; Baran Z; Cengisiz C; Çinar C; Erol A; Genç Y; Karadağ H; Karakülah K; Karasu U; Kaya MC; Kizil E; Özcan H; Tiryaki A; Üçok A; Varlik C; Yazar SM; Yildiz M
    J Clin Psychopharmacol; 2019; 39(6):604-610. PubMed ID: 31688391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement.
    Muser E; Kozma CM; Benson CJ; Mao L; Starr HL; Alphs L; Fastenau J
    J Med Econ; 2015; 18(8):637-45. PubMed ID: 25851616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Delirium Related to Oral Paliperidone in Dementia: A Case Report.
    Tsai MC; Chang PT; Yang CH; Liu ME
    J Clin Psychopharmacol; 2016 Apr; 36(2):184-5. PubMed ID: 26872118
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of Paliperidone Palmitate and Second-Generation Oral Antipsychotics in Terms of Medication Adherence, Side Effects, and Quality of Life.
    Sağlam Aykut D
    J Clin Psychopharmacol; 2019; 39(1):57-62. PubMed ID: 30566417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics.
    Hargarter L; Cherubin P; Bergmans P; Keim S; Rancans E; Bez Y; Parellada E; Carpiniello B; Vidailhet P; Schreiner A
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():1-7. PubMed ID: 25448776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3-month formulation in patients with schizophrenia: A phase-1, single-dose, randomized, open-label study.
    Ravenstijn P; Remmerie B; Savitz A; Samtani MN; Nuamah I; Chang CT; De Meulder M; Hough D; Gopal S
    J Clin Pharmacol; 2016 Mar; 56(3):330-9. PubMed ID: 26189570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia.
    Schreiner A; Aadamsoo K; Altamura AC; Franco M; Gorwood P; Neznanov NG; Schronen J; Ucok A; Zink M; Janik A; Cherubin P; Lahaye M; Hargarter L
    Schizophr Res; 2015 Dec; 169(1-3):393-399. PubMed ID: 26431793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefit of extending the dosing interval of paliperidone palmitate on schizophrenics with mild cognitive dysfunction.
    Suzuki H; Hibino H; Inoue Y; Mikami A; Matsumoto H; Mikami K
    Asian J Psychiatr; 2017 Aug; 28():98-99. PubMed ID: 28784410
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment Continuation of 3 Second-Generation Antipsychotic Long-Acting Injections, and Oral Paliperidone in Patients With Schizophrenia for 2 Years.
    Suzuki H; Hibino H; Inoue Y; Takaya A
    J Clin Psychopharmacol; 2018 Dec; 38(6):649-650. PubMed ID: 30334868
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of paliperidone extended release in adolescents with schizophrenia: a randomized, double-blind study.
    Savitz AJ; Lane R; Nuamah I; Gopal S; Hough D
    J Am Acad Child Adolesc Psychiatry; 2015 Feb; 54(2):126-137.e1. PubMed ID: 25617253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can a 4-Month Tolerability Assessment With Paliperidone Palmitate 1-Monthly Prevent Neuroleptic Malignant Syndrome Associated With the 3-Monthly?: Analysis Based on a Spontaneous Reporting System Database in Japan.
    Misawa F; Fujii Y; Takeuchi H
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):206-207. PubMed ID: 33538535
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypersexuality associated with paliperidone.
    Çayköylü A; Karslıoğlu EH; Özer İ; Köksal AG
    Exp Clin Psychopharmacol; 2018 Apr; 26(2):109-112. PubMed ID: 29389211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label study.
    Miller BJ; Claxton A; Du Y; Weiden PJ; Potkin SG
    Schizophr Res; 2019 Jun; 208():44-48. PubMed ID: 30745067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment effect with paliperidone palmitate compared with oral antipsychotics in patients with recent-onset versus more chronic schizophrenia and a history of criminal justice system involvement.
    Alphs L; Bossie C; Mao L; Lee E; Starr HL
    Early Interv Psychiatry; 2018 Feb; 12(1):55-65. PubMed ID: 26403322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Switch to 3-Month Long-Acting Injectable Paliperidone May Decrease Plasma Levels: A Case Series.
    Cellini L; De Donatis D; Mercolini L; Panariello F; De Ronchi D; Serretti A; Conca A; Gaspari D; Giupponi G; Zernig G; Florio V
    J Clin Psychopharmacol; 2021 Nov-Dec 01; 41(6):694-696. PubMed ID: 34735103
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety.
    Morris MT; Tarpada SP
    Psychopharmacol Bull; 2017 May; 47(2):42-52. PubMed ID: 28626271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study.
    Davidson M; Emsley R; Kramer M; Ford L; Pan G; Lim P; Eerdekens M
    Schizophr Res; 2007 Jul; 93(1-3):117-30. PubMed ID: 17466492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "I live, I don't work, but I live a very normal life"-A qualitative interview study of Scandinavian user experiences of schizophrenia, antipsychotic medication, and personal recovery processes.
    Møllerhøj J; Os Stølan L; Erdner A; Hedberg B; Stahl K; Riise J; Jedenius E; Rise MB
    Perspect Psychiatr Care; 2020 Apr; 56(2):371-378. PubMed ID: 31633213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed-onset of psychopharmacologically induced priapism: A cautionary case report.
    Birur B; Fargason RE; Moore N
    Asian J Psychiatr; 2015 Oct; 17():106. PubMed ID: 26188724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.